AstraZeneca bosses warn against rush for boosters
Data on whether they are needed is still awaited but ministers say the NHS is ready to go if they are….
In their article, AstraZeneca chief-executive Pascal Soriot and biopharmaceuticals-research-and-development executive-vice-president Sir Mene Pangalos say giving the most vulnerable, who may not have built up a full immune response from the first two, a third, top-up dose is “sensible”.
About The Author
